President and Chief Technology OfficerHemoSavin Pharmaceuticals, IncFort Collins, Colorado, United States
PB0249 - Development of the first small molecule therapy for the treatment of hemophilia A and B
Sunday, June 23, 202413:45 – 14:45 ICT